Stockreport

Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, July 22, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases [Read more]